(Q51626246)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19605511%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

title

Prognostic impact of age and gender in 897 untreated patients with primary myelodysplastic syndromes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19605511%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19605511%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

T Nösslinger

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19605511%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

H Tüchler

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19605511%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

U Germing

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19605511%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

W R Sperr

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19605511%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

O Krieger

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19605511%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

D Haase

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19605511%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

M Lübbert

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19605511%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

R Stauder

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19605511%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

A Giagounidis

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19605511%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

M Pfeilstöcker

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19605511%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

publication date

15 July 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19605511%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19605511%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19605511%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

120-125

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19605511%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19605511%20AND%20SRC:MED&resulttype=core&format=json

Proposals for the classification of the myelodysplastic syndromes

2 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP264

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP264

Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP264

Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP264

Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP264

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP264

Clinical, morphological, cytogenetic, and prognostic features of patients with myelodysplastic syndromes and del(5q) including band q31

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP264

Efficacy of lenalidomide in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP264

Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP264

Low-dose 5-aza-2'-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP264